Hard-hit cannabinoid firms in the US and Canada are reassessing their market strategies, restructuring, and downsizing – in some cases with significant job cuts – as the market remains volatile
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields